
Cellebrite DI Ltd.
NASDAQ:CLBT
19.64 (USD) • At close April 25, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|---|
Assets: | ||||||
Current Assets: | ||||||
Cash & Cash Equivalents
| 191.659 | 189.517 | 87.645 | 145.973 | 128.709 | 76.546 |
Short Term Investments
| 255.564 | 113.406 | 95.978 | 35.592 | 108.928 | 123.706 |
Cash and Short Term Investments
| 447.223 | 302.923 | 183.623 | 181.565 | 237.637 | 200.252 |
Net Receivables
| 82.358 | 77.269 | 78.761 | 67.505 | 66.324 | 44.237 |
Inventory
| 8.939 | 9.94 | 10.176 | 6.511 | 4.754 | 3.96 |
Other Current Assets
| 29.073 | 31.95 | 23.371 | 16.804 | 15.555 | 13.434 |
Total Current Assets
| 567.593 | 422.082 | 295.931 | 273.212 | 324.27 | 261.883 |
Non-Current Assets: | ||||||
Property, Plant & Equipment, Net
| 27.599 | 30.156 | 32.912 | 16.756 | 16.106 | 14.824 |
Goodwill
| 28.714 | 26.829 | 26.829 | 26.829 | 9.463 | 0 |
Intangible Assets
| 11.306 | 10.594 | 11.254 | 11.228 | 6.611 | 0 |
Goodwill and Intangible Assets
| 40.02 | 37.423 | 38.083 | 38.057 | 16.074 | 0 |
Long Term Investments
| 36.601 | 28.859 | 22.125 | 0 | 0 | 0 |
Tax Assets
| 11.072 | 14.536 | 12.511 | 9.8 | 7.372 | 3.086 |
Other Non-Current Assets
| 7.682 | 12.891 | 1.731 | 1.958 | 0.565 | 0.447 |
Total Non-Current Assets
| 122.974 | 123.865 | 107.362 | 66.571 | 40.117 | 18.357 |
Total Assets
| 690.567 | 532.885 | 403.293 | 339.783 | 364.387 | 280.24 |
Liabilities & Equity: | ||||||
Current Liabilities: | ||||||
Account Payables
| 11.077 | 8.282 | 4.612 | 9.546 | 4.727 | 5.36 |
Short Term Debt
| 0 | 4.972 | 5.003 | 0 | 0 | 0 |
Tax Payables
| 0.756 | 0.833 | 2.853 | 8.235 | 6.61 | 1.272 |
Deferred Revenue
| 216.97 | 196.587 | 152.709 | 122.983 | 106.102 | 69.792 |
Other Current Liabilities
| 66.699 | 43.15 | 41.972 | 45.114 | 41.943 | 22.736 |
Total Current Liabilities
| 295.502 | 253.824 | 207.777 | 186.573 | 159.382 | 99.16 |
Non-Current Liabilities: | ||||||
Long Term Debt
| 6.844 | 9.157 | 10.353 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 45.247 | 47.098 | 42.173 | 36.426 | 33.439 | 18.928 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 5.532 | 2.676 | 2.757 | 0 |
Other Non-Current Liabilities
| 6.954 | 188.594 | 69.125 | 190.133 | 107.762 | 103.324 |
Total Non-Current Liabilities
| 59.045 | 244.849 | 121.651 | 226.559 | 141.201 | 122.252 |
Total Liabilities
| 354.547 | 498.673 | 329.428 | 413.132 | 300.583 | 221.412 |
Equity: | ||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 101.205 | 101.205 |
Common Stock
| 0 | 0 | 0 | 0 | 0 | 0 |
Retained Earnings
| -164.864 | 118.143 | 199.243 | 78.436 | 28.342 | 32.561 |
Accumulated Other Comprehensive Income/Loss
| 2.086 | 1.05 | 0.331 | 1.372 | 1.321 | 0.804 |
Other Total Stockholders Equity
| 498.798 | -84.981 | -125.709 | -153.157 | -67.064 | -75.742 |
Total Shareholders Equity
| 336.02 | 34.212 | 73.865 | -73.349 | 63.804 | 58.828 |
Total Equity
| 336.02 | 34.212 | 73.865 | -73.349 | 63.804 | 58.828 |
Total Liabilities & Shareholders Equity
| 690.567 | 532.885 | 403.293 | 339.783 | 364.387 | 280.24 |